This is the foundational guide every researcher new to peptide science should read. Below, you will find a complete introduction to what peptides are, why they have become one of the most studied compound classes in research chemistry, how they differ from small molecules and proteins, and where the current frontiers of peptide research are heading.

What Is a Peptide?

A peptide is a short chain of amino acids — the same building blocks that proteins are made of — linked together by peptide bonds. The technical boundary between a peptide and a protein is fuzzy, but most researchers use the working definition that peptides contain between 2 and 50 amino acids, while proteins contain more than 50. Below 50 amino acids, the molecule typically lacks the complex tertiary folding structure that defines a functional protein.

Peptides occur naturally throughout biology. Insulin (51 amino acids — borderline) regulates blood glucose. Oxytocin (9 amino acids) is a hypothalamic peptide involved in social bonding. Bradykinin (9 amino acids) is a vasoactive peptide in the inflammatory cascade. Antimicrobial peptides produced by immune cells are the body’s rapid-response defence against bacterial invasion. The diversity of biological function packed into these short amino acid chains is what makes peptide research one of the most active fields in modern molecular science.

Why Peptides Matter in Modern Research

Peptides occupy a sweet spot in the chemical landscape that small molecules and proteins cannot reach. Compared to small-molecule drugs, peptides are:

• More selective. Peptide structure can be tuned to bind specific receptors with high specificity, reducing off-target effects.
• More potent at lower doses. Receptor binding affinities for well-designed peptides can be orders of magnitude higher than small molecules.
• Less toxic at metabolic clearance. Peptides break down into amino acids — the body’s own building blocks — rather than accumulating xenobiotic metabolites.

Compared to protein-based therapeutics, peptides are:

• Easier to synthesise. Solid-phase peptide synthesis (SPPS) can produce most research peptides in milligram-to-gram quantities reliably.
• Cheaper to manufacture. A single peptide synthesis run costs a fraction of what recombinant protein production requires.
• More stable in lyophilised form. Lyophilised peptides can be stored for years; recombinant proteins often require complex stabilisation strategies.

The Major Classes of Research Peptides

Research peptides span a wide range of biological functions. The most actively-studied classes:

• GLP-1 agonists (e.g. semaglutide, tirzepatide, retatrutide): incretin-mimicking peptides studied for metabolic and body composition research.
• Growth hormone secretagogues (e.g. ipamorelin, tesamorelin): peptides that modulate the GH/IGF-1 axis.
• Tissue regeneration peptides (e.g. BPC-157, TB-500): compounds studied for their role in cellular repair pathways.
• Mitochondrial peptides (e.g. SS-31/elamipretide, MOTS-c): peptides targeting mitochondrial function and cellular energy.
• Copper-bound peptides (e.g. GHK-Cu): studied for skin and extracellular matrix research.
• Nootropic peptides (e.g. semax, selank): investigated for their effects on neurotransmitter systems and cognition models.

What Makes a Research-Grade Peptide

The phrase “research-grade” carries specific meaning in peptide procurement. A research-grade peptide meets, at minimum, these criteria:

• HPLC purity ≥99%. Verified by High-Performance Liquid Chromatography with documented chromatogram.
• Mass spectrometry confirmation. Observed mass matches theoretical mass within typical instrumentation accuracy.
• Karl Fischer titration documented. Moisture content typically below 5%, often below 2%.
• Certificate of Analysis (CoA) per batch. Traceable analytical data linked to a unique batch number.
• Cold-chain logistics. Shipped refrigerated to preserve peptide integrity during transit.
• Lyophilised under controlled conditions. Properly freeze-dried with documented cycle parameters.

Material that does not meet these criteria — whether it costs €5 or €500 per vial — should not be used in any research that requires reproducible results.

The Current Frontiers

Where is peptide research heading? Three vectors stand out:

• Multi-receptor agonists. Compounds like retatrutide (triple-agonist GLP-1/GIP/glucagon) are demonstrating that simultaneous engagement of multiple receptors can produce effects no single-target compound has matched.
• Pen-formulated research material. Pre-filled research pens eliminate reconstitution variability and enable more consistent protocol delivery across multi-session research designs.
• Compound stacking research. Custom blends (such as TB-500 + BPC-157 + KPV combinations) are being studied for synergistic effects that single compounds do not produce.

Where to Go Next

If you are starting your research peptide procurement journey, the next articles in this knowledge base will deepen the key topics:

• Research Use Only (RUO) — the regulatory classification of research peptides
• HPLC Purity ≥99% — how purity is verified analytically
• Cold-Chain Logistics — why 2-8°C transport matters
• Certificate of Analysis — what every CoA should contain
• Lyophilisation & Reconstitution — the science behind freeze-drying
• REACH & CLP Compliance — the EU regulatory framework

For qualified researchers ready to procure verified research peptides: browse the Chempeptides catalogue. ≥99% HPLC purity, EU-based supply, cold-chain delivered, CoA on request. Research-use only.